Featured Open Lecture: July-August 2024

Gene therapy in lipid metabolism and CVD by Prof Sekar Kathiresan

Sekar Kathiresan is the Chief Executive Officer and founder of Verve Therapeutics, US. Previously, he was a Professor of Medicine at Harvard Medical School and the Director of the Center for Genomic Medicine in Boston, USA.

As a leading researcher in the field of the genetic background of cardiovascular disease, his work has enhanced the understanding of the inherited basis for blood lipids and myocardial infarction. In recent years, gene therapy has become a reality for several monogenic diseases.

In this lecture, he will explore the recent advances in gene therapy for treating dyslipidemia to prevent heart attacks.

To the Open Lecture by Prof Sekar Kathiresan